Transplantation Proceedings
Volume 36, Issue 2 , Pages 364-366, March 2004

The colon displays an absorptive capacity of tacrolimus

  • K Nishi

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan
    • Corresponding Author InformationAddress reprint requests to Kotaro Nishi, Department of Pediatric Surgery, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574 Japan.
  • ,
  • T Ishii

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan
  • ,
  • M Wada

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan
  • ,
  • S Amae

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan
  • ,
  • N Sano

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan
  • ,
  • M Nio

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan
  • ,
  • Y Hayashi

      Affiliations

    • Department of Pediatric Surgery, Tohoku University School of Medicine, Sendai, Japan

Abstract 

Purpose

In our previous study, blood levels of orally administered tacrolimus were significantly higher in short bowel piglets than in control animals. It has been reported that the blood levels of tacrolimus are influenced by the metabolic activity of intestinal CYP3A4. If tacrolimus may be absorbed in the colon, direct administration of drug into this organ might be useful to augment bioavailability since the expression of CYP3A4 is low at this site. In the present study we evaluated the absorptive capacity of tacrolimus in the colon.

Materials and methods

Piglets were divided into four groups: groups 1 and 2 were controls (n = 11 and 3, respectively); group 3 underwent resection of the entire small intestine (n = 8); and group 4 had a catheter placed in the cecum (n = 4). In groups 1 and 3, tacrolimus was administered orally; in group 2 it was given intravenously; and in group 4 it was injected into cecum through the catheter from postoperative days 3 to 7. On day 7, blood samples were obtained for drug measurements to calculate the area under the concentration time curve (AUC) values.

Results

The trough level and AUC values of tacrolimus in group 4 as well as in group 3 were significantly higher than those in group 1. In Group 4 animals showed a 60-minute time to peak concentration.

Conclusions

Tacrolimus is absorbed by the colon. Since the blood levels were not influenced by the metabolic activity in the graft bowel, direct administration of tacrolimus into the colon might be useful in small intestinal transplantation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0041-1345(03)01324-1

doi:10.1016/j.transproceed.2003.12.013

Transplantation Proceedings
Volume 36, Issue 2 , Pages 364-366, March 2004